IRS
CRL icon

Invictus RG (Singapore)’s Charles River Laboratories CRL Stock Holding History

Invictus RG (Singapore)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,687
Closed -$171K – 109
2015
Q3 		$171K Buy
2,687
+44
+2% +$3.16K 0.16% 249
2015
Q2 		$186K Buy
+2,643
New +$196K 0.17% 230
2015
Q1 		– Sell
-1,900
Closed -$121K – 601
2014
Q4 		$121K Sell
1,900
-300
-14% -$18.8K 0.13% 267
2014
Q3 		$131K Sell
2,200
-724
-25% -$41.4K 0.17% 235
2014
Q2 		$156K Buy
+2,924
New +$160K 0.16% 241

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invictus RG (Singapore)'s CRL Position: Q4 2015 in Review

Invictus RG (Singapore) sold out of Charles River Laboratories (CRL) in Q4 2015, closing a stake of 2,687 shares — an estimated $171K sold.

Invictus RG (Singapore) first reported a position in CRL in Q2 2014 and held it in 5 quarters. The position peaked at $186K in Q2 2015. 268 funds tracked by Wall St. Rank hold CRL as of Q4 2015.

  • Invictus RG (Singapore) reported no remaining Charles River Laboratories position as of Q4 2015 after selling out during the quarter.
  • Invictus RG (Singapore) sold 2,687 Charles River Laboratories shares in Q4 2015, an estimated $171K.
  • Invictus RG (Singapore) first reported a position in Charles River Laboratories in Q2 2014 and held it in 5 quarters.
  • Invictus RG (Singapore)'s Charles River Laboratories position peaked at $186K in Q2 2015.
  • 268 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2015.